A Mab A Case Study In Bioprocess Development (2024)

: The study shifts the focus from "testing quality into the product" to "building quality into the process" through deep scientific understanding.

: Leveraging "prior knowledge" from similar molecules (platform technologies) significantly accelerates development. A Mab A Case Study In Bioprocess Development

Appendices (suggested)

The is a landmark document in the biopharmaceutical industry, serving as a comprehensive template for applying Quality by Design (QbD) principles to the development of monoclonal antibodies (mAbs) . Published in 2009 by the CMC Biotech Working Group , it simulates the development of a hypothetical IgG1 monoclonal antibody to demonstrate how systematic, risk-based approaches can enhance process understanding and ensure product quality. Core Framework of the A-Mab Study : The study shifts the focus from "testing